Double-Blind Study of Imipramine versus Phenelzine in Melancholias and Dysthymic Disorders | The British Journal of Psychiatry | Cambridge Core (original) (raw)

Abstract

In a 6-week double-blind trial, the efficacy of imipramine and high dose phenelzine were compared in the treatment of Major Depression with Melancholia, and Dysthymic Disorder (DSM-III). Both drugs were found to be equally efficacious in the treatment of 32 patients suffering from Major Depression. In 32 Dysthymic patients, phenelzine in high doses was found to be superior to imipramine. The clinical implications of these findings are discussed.

References

Carroll, B., Feinberg, M., Greden, J., Tarika, J., Albala, A., Haskett, R., James, N., Kronfol, Z., Lohr, N., Steiner, M., de Vigne, J. & Young, E. (1981) A specific laboratory test for the diagnosis of melancholia: standardization, validation and clinical utility. Archives of General Psychiatry, 38, 15–22.Google Scholar

Hamilton, M. (1982) The effect of treatment on the melancholias (depressions). British Journal of Psychiatry, 14, 223–230.CrossRefGoogle Scholar

Klein, D. & Davis, J. (1969) Diagnosis and Drug Treatment of Psychiatric Disorders, Baltimore: Williams & Wilkins.Google Scholar

Liebowitz, M., Quitkin, F., Stewart, J., McGrath, P., Harrison, W., Rabkin, J., Tricamo, E., Markowitz, J. & Klein, D. (1984) Phenelzine vs. imipramine in atypical depression. Archives of General Psychiatry, 41, 669–677.Google Scholar

Medical Research Council (1965) Clinical trial of the treatment of depressive illness. British Medical Journal, i, 881–886.Google Scholar

Nies, S. & Robinson, B. (1981) Comparison of clinical effects of amitriptyline and phelenzine treatment. In Monoamine Oxidase Inhibitors: the State of the Art (eds Youdim, M. & Paykel, E.). Chichester: John Wiley & Sons.Google Scholar

Paykel, E., Rowan, P., Parker, R. & Bmat, A. (1982) Response to phenelzine amitriptyline in subtypes of out-patient depression. Archives of General Psychiatry, 39, 1041–1049.Google Scholar

Rees, L. & Davies, B. (1961) Controlled trial of phenelzine (Nardil) in treatment of severe depressive illness. Journal of Mental Sciences, 107, 560–566.Google Scholar

Robinson, D., Nies, A., Ravaris, L. & Lamborn, K. (1973) The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states. Archives of General Psychiatry, 29, 407–413.CrossRefGoogle ScholarPubMed

Rowan, P., Paykel, E., Parker, R. (1982) Phenelzine and amitriptyline: effects on symptoms of neurotic depression. British Journal of Psychiatry, 140, 475–483.Google Scholar

West, E. & Dally, P. (1959) Effects of iproniazid in depressive syndromes. British Medical Journal, i, 1491–1494.Google Scholar

Young, J., Lader, M. & Hughes, W. (1979) Controlled trial of trimipramine, monoamine oxidase inhibitors and combined treatment in depressed out-patients. British Medical Journal, ii, 1315–1317.CrossRefGoogle Scholar